MSN Labs enters into Licensing Agreement with Eli Lilly to launch Baricitinib in India for COVID
MSN Labs (MSN) on Thursday announced that they have entered into a royalty free, non-exclusive, voluntary license agreement with the ...
Tag: MSN Labs
COVID 19 : MSN Labs launches Favilow 800 mg tablets
In order to address the shortage of the antiviral drug Faripiravir, to treat mild and moderate COVID-19 flu, MSN Laboratories ...
Latest News
